scholarly journals Microinvasive Carcinoma versus Ductal CarcinomaIn Situ: A Comparison of Clinicopathological Features and Clinical Outcomes

2018 ◽  
Vol 21 (2) ◽  
pp. 197 ◽  
Author(s):  
Milim Kim ◽  
Hyun Jeong Kim ◽  
Yul Ri Chung ◽  
Eunyoung Kang ◽  
Eun-Kyu Kim ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Clinicopathological Features ◽  
Ductal Carcinomain Situ ◽  
Carcinomain Situ ◽  
Microinvasive Carcinoma

Ductal carcinomain situ: how should we treat it?

2013 ◽  
Vol 2 (3) ◽  
pp. 245-256
Author(s):  
Soley Bayraktar ◽  
Banu Arun ◽  
Stefan Glück
Keyword(s):  
Ductal Carcinomain Situ ◽  
Carcinomain Situ

PARP1 as a prognostic biomarker for human cancers: a meta-analysis

2021 ◽  
Author(s):  
Yan-Hua Huang ◽  
Sun-Jun Yin ◽  
Yuan-Yuan Gong ◽  
Zhi-Ran Li ◽  
Qin Yang ◽  
...  
Keyword(s):  
Overall Survival ◽  
Clinical Outcomes ◽  
Bioinformatics Analysis ◽  
Prognostic Biomarker ◽  
Meta Analysis ◽  
Bioinformatic Analysis ◽  
Clinicopathological Features ◽  
Poor Overall Survival ◽  
Human Cancers

Aim: A comprehensive meta-analysis was carried out to evaluate the association between high PARP1 expression and clinical outcomes in diverse types of cancers. Materials & methods: The electronic databases for all articles about PARP1 expression and cancers were searched. Additionally, bioinformatics analysis was utilized to validate the results of the meta-analysis. Results: Fifty-two studies with a total of 7140 patients were included in the current meta-analysis. High PARP1 expression was found to be significantly associated with poor overall survival and recurrence in various cancers, which were further strengthened and complemented by the results of bioinformatic analysis. Furthermore, increased PAPR1 expression was also related to clinicopathological features. Conclusion: Our findings confirmed that PARP1 might be a promising biomarker for prognosis in human cancers.

Ductal carcinomain situ of the breast

1997 ◽  
Vol 84 (2) ◽  
pp. 145-146 ◽  
Author(s):  
M. J. Silverstein
Keyword(s):  
Ductal Carcinomain Situ ◽  
Carcinomain Situ

Ductal carcinomain situ- update on risk assessment and management

2015 ◽  
Vol 68 (1) ◽  
pp. 96-109 ◽  
Author(s):  
Jia-Min B Pang ◽  
Kylie L Gorringe ◽  
Stephen B Fox
Keyword(s):  
Risk Assessment ◽  
Ductal Carcinomain Situ ◽  
Carcinomain Situ ◽  
Risk Assessment And Management

scholarly journals Selection of Treatment Among Latina and Non-Latina White Women with Ductal Carcinomain Situ

2011 ◽  
Vol 20 (2) ◽  
pp. 215-223 ◽  
Author(s):  
Celia P. Kaplan ◽  
Anna M. Nápoles ◽  
E. Shelley Hwang ◽  
Joan Bloom ◽  
Susan Stewart ◽  
...  
Keyword(s):  
White Women ◽  
Ductal Carcinomain Situ ◽  
Carcinomain Situ ◽  
Selection Of

Microsatellite instability in ductal carcinomain situ of the breast

1998 ◽  
Vol 185 (1) ◽  
pp. 18-24 ◽  
Author(s):  
Tom Walsh ◽  
Stephen A. Chappell ◽  
Jacqui A. Shaw ◽  
Rosemary A. Walker
Keyword(s):  
Microsatellite Instability ◽  
Ductal Carcinomain Situ ◽  
Carcinomain Situ

Abstract 1404: The nuclear coactivator amplified in breast cancer 1 promotes the initiation and the development of ductal carcinomain situ.

2013 ◽  
Author(s):  
Virginie Ory ◽  
Elena Tassi ◽  
Luciane Cavalli ◽  
Francisco Saenz ◽  
Tabari Baker ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ductal Carcinomain Situ ◽  
Carcinomain Situ
Sign in / Sign up

Export Citation Format

Share Document